We’re committed to uncompromising performance.
Chardan is an independent, full-service global investment bank specializing in healthcare, disruptive technologies, and SPACs that deliver remarkable, enduring returns. Focused on bringing disruptive innovation to corporate and institutional clients, Chardan has established a leading SPAC practice, with a 17-year history, nearly 90 SPACs underwritten, 10 self or co-sponsored SPACs, and notably, zero liquidations. Additionally, since 2018 Chardan has acted as M&A advisor in 22 SPAC merger transactions. Headquartered in New York City, Chardan is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: FINRA, SIPC, NASDAQ and the NYSE Arca, Inc
-
Specialized
We’re focused on enabling healthcare and disruptive technologies.
-
Purposeful
We seek enduring opportunities that change lives and drive society forward.
-
Insightful
Our unique research enables us to successfully uncover emergent growth areas.
-
Unflinching
Our point of view is direct and intellectually honest—because it’s well-informed.
Unique opportunities. Global reach.
Meet our leadership.
-
Steven Urbach
Co-Founder and CEO
-
Jonas Grossman
President
-
Kerry Propper
Co-Founder and Non-Executive Chairman
-
Gbola Amusa, MD, CFA
Partner and Chief Scientific Officer
-
Scott Blakeman
Partner, Head of Equity Trading
-
Shai Gerson
Partner, Capital Markets
-
George Kaufman
Partner, Head of Investment Banking
-
Emily Levine
Chief Commercial Officer
-
Ron Glickman
Managing Director, Business Development
-
Murat Omur
Managing Director and Head of Healthcare Investment Banking
-
Alex Weil
Managing Director, Co-Head FinTech Investment Banking
We believe in moving society forward.
Chardan Cares
Work at Chardan.
Our departments include:
- Research
- Investment Banking
- Institutional Equities
- Operations
Thank You!
We've received your information, and we're processing your request.